'active substances emtricitabine'

Teevir Tablets contain two active substances, Emtricitabine and Tenofovir disoproxil fumarate. These medications are a part of the standard combination therapy for HIV, known as antiretroviral therapy (ART). It is a combination drug regimen that is commonly used for the effective treatment of HIV-1 infection. When used correctly and consistently, Teevir tablets have demonstrated high efficacy in HIV treatment and prevention. Antiviral medications help postpone the effects of AIDS and enhance the overall quality of life. For individuals with high viral loads, this combo therapy is ideal. Although this medication greatly lowers the risk of viral infection, it does not treat HIV, and there are still chances that HIV will spread to other individuals. It is given to adults and kids over the age of 12 with a body weight of more than 35 kg.

FAILED

Taficita tablet contains the active ingredient Emtricitabine/ tenofovir alafenamide. It is a combination of antiretroviral medication. Emtricitabine belongs to the class of medication called nucleoside reverse transcriptase inhibitor (NRTI), and tenofovir alafenamide belongs to the class called nucleotide reverse transcriptase inhibitor (NtRTI). It is used in combination with other medicines to treat human immunodeficiency virus (HIV-1) infection in adults and adolescents 12 years of age and who weigh at least 35kg. They work by slowing the spread of HIV in the body. Do not take Taficita tablet if you are allergic to Emtricitabine/ tenofovir alafenamide or any of the other ingredients. Get tested for HIV infection regularly while using this medicine. Do not miss any doses of this medicine or stop taking it. Missing doses may increase your risk of getting HIV infection. This medicine does not prevent other sexually transmitted infections (STIs). Inform your physician if you have liver problems or suffer from liver disease, including hepatitis, kidney problems, and bone problems. Do not give this medicine to children aged 11 years or under.

FAILED

Oral Semaglutide Tablets For Weight Loss 3mg 7mg 14mg Tablets Get Best Quote Request Callback ₹ 3149 / Pack Get Latest Price Product Brochure Form Tablets Packaging Type Box Composition Semaglutide Packaging Size 1 X 10 Brand RYBELSUS Manufacturer NOVO NORDISK Shelf Life 24 Months Usuage to treat type 2 diabetes Prescription / Non Prescription Prescription Usage WEIGHT LOSS RYBELSUS® (semaglutide) tablets 3mg, 7 mg or 14 mg is a prescription medicine used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes. It is not known if RYBELSUS® can be used in people who have had pancreatitis RYBELSUS® is not for use in people with type 1 diabetes It is not known if RYBELSUS® is safe and effective for use in children under 18 years of age Key takeaways: Rybelsus (semaglutide) is an oral medication approved to treat Type 2 diabetes. It contains the same active ingredient as Ozempic and Wegovy. Ozempic is approved for Type 2 diabetes, and Wegovy is approved for chronic weight management. Rybelsus is currently being studied for weight loss in clinical trials. These studies involve higher doses than what’s currently approved and available for diabetes. Results show that an oral semaglutide (Rybelsus) dose of 50 mg results in similar weight loss as Wegovy. Due to these findings, Rybelsus’ manufacturer plans to request FDA approval in 2023. If approved for weight loss, it may be marketed under a different brand name. Yes! I am interested Rybelsus Semaglutide 3Mg 7Mg 14Mg Tablets Get Best Quote Request Callback ₹ 2900 / Stripe Get Latest Price Product Brochure Form Tablets Packaging size 10*10 Tablets Packaging Type Strip Composition Semaglutide Brand Rybelsus Shelf Life 24 Months Usuage to treat type 2 diabetes Prescription / Non Prescription Prescription strength 3 mg RYBELSUS® (semaglutide) tablets 3mg, 7 mg or 14 mg is a prescription medicine used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes. It is not known if RYBELSUS® can be used in people who have had pancreatitis RYBELSUS® is not for use in people with type 1 diabetes It is not known if RYBELSUS® is safe and effective for use in children under 18 years of age Key takeaways: Rybelsus (semaglutide) is an oral medication approved to treat Type 2 diabetes. It contains the same active ingredient as Ozempic and Wegovy. Ozempic is approved for Type 2 diabetes, and Wegovy is approved for chronic weight management. Rybelsus is currently being studied for weight loss in clinical trials. These studies involve higher doses than what’s currently approved and available for diabetes. Results show that an oral semaglutide (Rybelsus) dose of 50 mg results in similar weight loss as Wegovy. Due to these findings, Rybelsus’ manufacturer plans to request FDA approval in 2023. If approved for weight loss, it may be marketed under a different brand name. Yes! I am interested Victoza Liraglutide Injection Get Best Quote Request Callback ₹ 4800 / Piece Get Latest Price Product Brochure Strength 6 mg/ ml Packaging Type Vial Brand Victozoa Usage / Application Personal Shelf Life 24 Months Country of Origin Made in India Liraglutide injection (Victoza) is used with a diet and exercise program to control blood sugar levels in adults and children 10 years of age and older with type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood) when other medications Yes! I am interested BEMPIFY 180MG 100 TAB BEMPEDOIC ACID Get Best Quote Request Callback ₹ 100 / Stripe Get Latest Price Product Brochure Packaging Size 10*10 Tablets Packaging Type Stripe Strength 180 mg Brand BEMPIFY 180MG Country of Origin Made in India Bempify Tablet 180mg is used to lower cholesterol and reduce the risk of heart disease. Cholesterol is a fatty substance that builds up in your blood vessels and causes narrowing, possibly leading to a heart attack or stroke. Yes! I am interested Mounjaro Tirzepatide 5mg/0.5ml Injection Get Best Quote Request Callback ₹ 5999 / Vial Get Latest Price Product Brochure Strength 5 mg Packaging Size 0.5 ml Packaging Type Injection Brand Maunjaro Manufacturer Eli Lilly and Company India Pvt Ltd Prescription No Usage / Application Management of Obesity Mounjaro 5mg Solution for Injection is a prescription medicine used to improve blood sugar control in adults with type 2 diabetes and support weight management in individuals who are overweight and those with obesity. It works by mimicking natural hormones to enhance insulin secretion and regulate appetite. Mounjaro 5mg Solution for Injection is administered once weekly subcutaneously in the abdomen, thigh, or upper arm. To maximize its benefits, maintain a consistent injection schedule and complement treatment with a healthy diet and regular exercise. Follow your doctor’s instructions carefully, including any dose adjustments, and store the me

FAILED

Tadalista Super Active ₹ 200 / Stripe Get Latest Price Strength 20 mg Brand Tadalista Packaging Type Strip Composition Tadalafil 20 mg Form Tablets Usages To treat erectile dysfunction We are engaged in Offering wide range of Quality Products to our Clients, our Range of Products are really appreciated by our client.

FAILED

FILDENA SUPER ACTIVE 100 MG 100 CAP SILDENAFIL SOFTGEL ₹ 99 / Stripe Get Latest Price Strength 100 mg Pack Size 10 Tablets Brand FILDENA Form Tablet Country of Origin Made in India Minimum order quantity: 10 Stripe FILDENA SUPER ACTIVE is a prescription medicine used to treat erectile dysfunction (impotence) in men. It works by increasing blood flow to the penis. This helps men to get or maintain an erection. It belongs to a group of medicines known as phosphodiesterase type 5 (PDE 5) inhibitors Manufacturer /Marketed by FORTUNE HEALTHCARE Contains / Molecules SILDENAFIL CITRATE Strength 100 mg Packing 10*10 PER BOX International Name FILDENA SUPER ACT

FAILED

Myhep Lvir Ledipasvir And Sofosbuvir Tablets ₹ 4999 / Bottle Get Latest Price Product Brochure Strength 90mg/400mg Quantity Per Pack 28 Tabs Manufactured By MYLAN PHARMACEUTICALS PVT LTD Item Name Myhep Lvir Trade Name Myhep Lvir Usage Chronic Hepatitis C virus infection. Country of Origin Made in India Myhep Lvir Tablet is a medicine that contains the active substances ledipasvir and sofosbuvir. It is indicated to treat chronic (long-term) hepatitis C virus infection in adults and children three years of age and older. Hepatitis C is a virus that mainly infects the liver. It is mainly triggered by a virus named Flavivirus. Most patients remain asymptomatic, and the symptoms show up only when they develop chronic liver disease or cirrhosis. The progression of liver disease is faster in people who consume alcohol and those with a weak immune system. The main treatment goal for Hepatitis C infection is complete eradication of the virus causing this infection. This drug is contraindicated for individuals with decompensated cirrhosis or severe liver disease. In such cases, alternative treatment options should be considered. This drug should not be used if you have any known allergy or hypersensitivity to Myhep Lvir Tablet or other ingredients in the medication. Your liver function may change with the treatment of hepatitis C and, therefore, affect other medications (e.g., medicines used to suppress your immune system, etc.). Your doctor may need to monitor your other medicines and make dose adjustments closely. If you have liver disease other than hepatitis C, are awaiting a liver transplant, have a current or previous infection with the hepatitis B virus (HBV), or receive ongoing treatment for HIV infection. It's important to inform your doctor. They will consider these conditions before starting treatment. Talk to your doctor immediately before taking this drug if you have diabetes. You may need closer monitoring of your blood glucose levels or adjustment of your diabetes medication after starting this drug. Some diabetic patients have experienced low sugar levels in the blood (hypoglycemia) after starting treatment with medicines like Myhep Lvir Tablet. The doctor will test your blood before, during, and after your treatment with this medicine. So that your doctor can confirm that your treatment has worked and you are free of the hepatitis C virus, do not breastfeed during treatment with this tablet. It is unknown whether this drug passes into human breast milk. Consult your doctor if you are breastfeeding. Do not give this tablet to children under three years of age. The use of this drug has not yet been studied. This tablet can interact with certain medications, potentially affecting their efficacy or increasing the risk of side effects. It's necessary to inform your doctor about all your medications, including prescription, over-the-counter, and herbal supplements, to ensure no potential interactions. Uses of Myhep Lvir Tablet Chronic Hepatitis C virus infection

FAILED

Zoetis Simparica Trio chewable tablets offer advanced, all-in-one protection against ticks, fleas, heartworms, and intestinal worms in dogs. Each tablet includes three potent active substances that provide broad-spectrum parasite control to keep your pet healthy and free of parasites. Designed for dogs of all sizes, this chewable flea and tick treatment is very appetizing, making administration simple. The pack of three tablets provides three months of continuous protection, providing pet owners with a convenient option for flea, tick, and worm prevention. Simparica Trio for dogs provides long-lasting, efficient protection against dangerous parasites. Composition: SAROLANER + MOXIDECTIN + PYRANTEL Class: Anti-tick & flea tablet

FAILED

Kocitaf Tablet contains the active ingredient Kocitaf Tablet. It is a combination of antiretroviral medication. Dolutegravir belongs to a class of antiretroviral drugs called integrase strand transfer inhibitors (INSTIs). Emtricitabine belongs to the class of medication called nucleoside reverse transcriptase inhibitor (NRTI), and tenofovir alafenamide belongs to the class called nucleotide reverse transcriptase inhibitor (NtRTI). It is combined with other medicines to treat human immunodeficiency virus (HIV-1) infection in adults and adolescents 12 years of age who weigh at least 35kg. The combination is available as a single tablet regimen, simplifying treatment by reducing the number of pills a person must take daily. This convenience improves medication adherence, ensuring individuals can consistently take their prescribed medication as scheduled. Do not take Kocitaf Tablet if anyone is allergic to it or its components. Get tested for HIV infection regularly while using this medicine. Missing a dose increases the risk of getting HIV infection. This medicine does not prevent other sexually transmitted infections (STIs). Patients should inform the physician if they have liver problems or liver disease, including hepatitis, kidney, and bone problems. This medication is not recommended to give in to children aged 11 years or under.

FAILED

Emtricitabine + Tenofovir disoproxil fumarate + Efavirenz Uses Emtricitabine+Tenofovir disoproxil fumarate+Efavirenz is used in the treatment of HIV infection. How Emtricitabine + Tenofovir disoproxil fumarate + Efavirenz works Emtricitabine + Tenofovir disoproxil fumarate + Efavirenz is a combination of three antiviral medicines: Emtricitabine , Tenofovir disoproxil fumarate and Efavirenz. They work by preventing HIV (virus) from multiplying, thereby reducing the amount of virus in your body. They also increase the CD4 cell (white blood cells that protect against infection) count in your blood.

FAILED